Early recurrence in a pooled international cohort of melanoma patients treated with adjuvant nivolumab in a real-world setting
Saved in:
Main Authors: | L. Mortier, R. Gutzmer, V. Atkinson, S. Dalle, P. Saiag, B. Neyns, A. Rorive, P. Parente, M. Weichenthal, J.-J. Grob, C. Lebbé, P. Mohr, T. Eigentler, L. McDonald, L. Willemot, F. Brellier, O. Bakharevski, S. Houssou, M. Jadhao, D. Schadendorf |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | EJC Skin Cancer |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772611824001393 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
by: S. Dalle, et al.
Published: (2024-01-01) -
The RoMEO study: a real-world, observational, prospective investigation of dabrafenib and trametinib combination treatment in patients with BRAF V600 unresectable or metastatic cutaneous melanoma
by: L. Mortier, et al.
Published: (2024-01-01) -
First-line Nivolumab plus Ipilimumab in patients with advanced melanoma previously treated with adjuvant systemic therapy
by: K. Kisielewska, et al.
Published: (2024-01-01) -
A phase 3 study of the efficacy, safety, and pharmacokinetics profile of subcutaneous vs intravenous nivolumab + relatlimab fixed-dose combination in previously untreated metastatic or unresectable melanoma (RELATIVITY-127)
by: G.V. Long, et al.
Published: (2024-01-01) -
Preclinical comparison of prolgolimab, pembrolizumab and nivolumab
by: Aleksandr Gordeev, et al.
Published: (2024-10-01)